Your browser doesn't support javascript.
loading
Metabolic subtypes of clear cell renal cell carcinoma defined by tobacco smoking.
Czyzyk-Krzeska, Maria F; Meller, Jarek; Landero Figueroa, Julio A; Plas, David R; Cunningham, John T.
Afiliação
  • Czyzyk-Krzeska MF; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA.
  • Meller J; Department of Veterans Affairs, Cincinnati Veteran Affairs Medical Center, Cincinnati, OH, USA.
  • Landero Figueroa JA; Department of Biomedical Informatics, University of Cincinnati, Cincinnati, OH, USA.
  • Plas DR; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Cunningham JT; Division of Biostatistics and Bioinformatics, Department of Environmental and Public Health Sciences, University of Cincinnati, Cincinnati, OH, USA.
Mol Cell Oncol ; 8(2): 1859917, 2021.
Article em En | MEDLINE | ID: mdl-33860076
Tobacco smoking (TS) results in reprogramming of major metabolic pathways, including glycolysis, the citric acid (TCA) cycle, oxidative phosphorylation, and metabolism of aspartate, glutamate and glutamine in clear cell renal cell carcinoma (ccRCC). TS alters the distribution and activities of cadmium, arsenic and copper in a manner mechanistically supporting metabolic remodeling. Alterations in metabolism and metal distribution identify new actionable targets for treatment of ccRCC.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article